Online vendors legally sell unregulated peptides by labeling them "for research only," while simultaneously providing syringes, tutorials, and marketing that normalizes human injection. This strategy exploits a regulatory loophole to create a thriving market for untested performance-enhancing drugs.
Widespread emigration of young people, who are most likely to protest, has left Cuba with an aging population. This demographic shift naturally suppresses dissent and makes a popular uprising against the regime less likely, regardless of the severity of economic hardships.
The internet directly links Chinese chemical factories with online influencers and consumers. This ecosystem is supercharged by public access to scientific databases like PubMed, which allows for a "weird mix of plausible biological speculation" to be presented as credible science, bypassing all regulatory safeguards.
The US strategy in Cuba may not be to oust the Castro family entirely, but to replace the current president while leaving the core power structure and even Castro relatives intact. This mirrors the approach in Venezuela, suggesting a pragmatic rather than purely ideological goal.
The demand for unregulated peptides reflects a public belief that the formal medical system moves too slowly and stops short of addressing personal optimization goals. This perception drives consumers to risky, unregulated markets to access what they believe is the "fullest expression of modern medicine."
By crippling the Cuban government's ability to operate, US sanctions are forcing the regime to cede control of key sectors. For example, the state has had to hand off its monopoly on importing oil, allowing private businesses to import it for their own needs—an ironic push towards a free-market principle.